Delivery Order SPE2DB24D2100-SPE2DB25FBDUM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 28 units of Afinitor 5 mg tablets in unit dose packaging, valued at $37,057.56 under a firm fixed price contract type. The award, issued on October 27, 2025, is scheduled for completion by November 18, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This is a competitively awarded non-set-aside contract, reflecting the company's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Afinitor 10 mg tablets in unit dose packaging (28 count) with a ceiling value of $12,360.81. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,017.66 to AmerisourceBergen Drug Corp for Afinitor 5 mg tablets (28-count unit dose packaging) on November 7, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with DLA...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Afinitor Disperz 3 mg tablets in quantities of 28 units. This competitively awarded, non-set-aside contract carries a ceiling value of $47,663.84 under firm fixed pricing terms, with an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Afinitor Disperz 3 mg tablets in quantities of 28 count, with a ceiling value of $47,663.84 and an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the Defense Logistics...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,600.94, is a Firm Fixed Price Delivery Order for the supply of the drug Afinitor 2.5 mg tablet, with a completion date of May 2, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,333.53, is for the delivery of Afinitor Disperz 5 mg Tablets and has an ultimate completion date of April 24, 2025. This appears to be a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $24,721.64 firm fixed-price delivery order is for the supply of AFINITOR 10 MG TABLET UD 28S, a pharmaceutical product, with a completion date of March 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $10,000 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 2.5 mg tablets of AFINITOR to treat for a 28-day period. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, beginning in mid-September and concluding in early October of this year. The prime contractor, Amerisourcebergen Drug Corporation, is a division of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $20,112.96 firm fixed price delivery order is for the supply of Afinitor 2.5 mg tablet units. As a prime contractor, Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and medical supplies to support DLA Troop Support Medical facilities and programs. This contract does not have a set-aside designation. The...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBDUMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,721.64 to AmerisourceBergen Drug Corp for the supply of Afinitor 10 mg tablet unit dose packages (28-count) on April 24, 2025, with an ultimate completion date of May 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The place of performance is located in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling diverse medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 4/24/25 |